Menu

CRITICAL COVID-19 WORK

At the Innovative Genomics Institute, we have shifted our focus to the COVID-19 pandemic. We have set up a coronavirus testing facility and are pursuing research into new diagnostics, therapeutics, and other topics. Learn More >

Please consider supporting this urgent effort:

DONATE NOW

Related News

IGI in the Press

Follow

Twitter@igisci

Millions of people around the world depend on cassava as a staple crop, but it can cause cyanide poisoning if not processed correctly. In the latest CRISPR Cuts podcast, @jblphd and @MichaelGzRs discuss using #CRISPR to solve this problem: https://t.co/D12SM9c3Ra
📣 *Funding opportunity* for early career faculty @UCBerkeley, @ucdavis & @UCSF! The SKCF Scholars program will award $179k to a scientist using genomic technology in basic or applied research that aligns with our mission. Learn more & apply: https://t.co/zGCAeq4Iko
Read about the new clinical trial on a #CRISPR therapy for sickle cell disease, and how the IGI is developing next-generation techniques for in vivo delivery: https://t.co/3xkj675qEI
Get to know scientists with our #MeetAnIGIScientist series! Check out our recent interview with Josefina Coloma of @UCBerkeleySPH & @SSIGlobalHealth: And meet a collection of diverse IGI scientists in our archives! https://t.co/DRwoHc511Z https://t.co/zSyWfKXkSgStockholm Resilience Centre @sthlmresilience“I think science needs to be woven more into our daily lives than it has been in recent decades. To appreciate science people need to know scientists,” continues @NobelPrize Laureate Jennifer Doudna @UCBerkeley @igisci at #NobelPrizeSummit.